The coronavirus outbreak, first reported in central China's Wuhan City last December, has fast spread across the globe within months.
On afternoon March 29, 2020, Cai Wei and his entourage conducted an inspection trip to Shanghai Biotecan Biological Pharmaceuticals Co. Ltd, to learn about the resumption of work and the difficulties needs facing the enterprise.
On afternoon March 12, 2020, Tian Chunhua, the Standing Committee of the Shanghai Municipal People's Congress of the Pudong New Area, and his entourage, with the related leader of the Zhangjiang Administration, conducted an inspection trip to Shanghai Biotecan Biological Pharmaceuticals Co. Ltd, to learn about the resumption of work and the difficulties needs facing the enterprise.
Novel coronavirus pneumonia is escalating throughout the whole nation at the beginning of the new year. Facing the increasingly serious situation of prevention and control of pneumonia, Shanghai Biotecan is obliged to actively participate in the front line of epidemic prevention, and assume the task of detecting novel coronavirus. Relying on high technology, Shanghai Biotecan has provided strong support for rapid screening and diagnosis of patients, and has become a beautiful scenery of first-line of anti epidemic.
Good news comes in succession! Shanghai Biotecan Clinical Laboratory successfully passed the verification of detection capability for SARS-CoV-2, helping Biotecan become one of the firstly certified Independent Clinical Laboratories for new crown virus detection in China.
A sudden outbreak of prevention and control of the war suddenly started, everyone is heart leading Wuhan and sincerely looking forward to it. As a leading company in the field of precision medicine, since the outbreak of the epidemic, the Biotech commando team fighting on the front line of the epidemic has taken the initiative to take on the task of detecting COVID-19, relying on high technology to provide strong support for rapid screening and diagnosis of patients; The molecular medical laboratories that Biotech cooperate with various hospitals in China actively cooperate with the hospital's deployment, and are willing to suspend ongoing daily testing to provide laboratory sites, instruments, personnel, consumables, etc. that meet the requirements for anti-epidemic and anti-virus. Biotech has made its due contribution to win the epidemic battle early, and to better protect the health and life of the people.
First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China